Cellectis SA Stock Xetra
Equities
ZVA
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 27.87M 30.39M | Sales 2025 * | 59.33M 64.71M | Capitalization | 133M 145M |
---|---|---|---|---|---|
Net income 2024 * | -40M -43.62M | Net income 2025 * | -63M -68.7M | EV / Sales 2024 * | -1.09 x |
Net cash position 2024 * | 163M 178M | Net cash position 2025 * | 88.23M 96.22M | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.85% |
Latest transcript on Cellectis SA
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
1st Jan change | Capi. | |
---|---|---|
+22.10% | 47.07B | |
+46.45% | 42.06B | |
-3.12% | 39.98B | |
+36.10% | 33.02B | |
-6.30% | 27.9B | |
+18.71% | 27.63B | |
+46.15% | 14.37B | |
+44.52% | 13.45B | |
+0.19% | 12.03B |